Company: LBRX
Filing Date: 2025-07-23
Form Type: DRS/A
Source: 0000950123-25-006557
Chunk: 139

Company: LB PHARMACEUTICALS INC
Filing Date: 2025-07-23
Form: DRS/A
Chunk 139
---
 be reduced to % of the total number of shares of our common stock outstanding after this offering, and the percentage of our common stock held by new investors would be increased to % of the total number of shares of our common stock outstanding after this offering. 92

The number of shares of our common stock to be outstanding after this offering is based on shares of common stock outstanding as of (including shares of restricted common stock that remained unvested and subject to forfeiture as of such date), after giving effect to the conversion of all of our outstanding shares of redeemable convertible preferred stock into shares of common stock upon the closing of this offering and excludes:

| • |     | shares of common stock issuable upon the exercise of outstanding stock options under 
 our 2023 Plan as of     , at a weighted-average exercise price of $    per share;    |

| • |     | shares of common stock issuable upon the exercise of outstanding stock options under 
 our 2018 Plan as of     , at a weighted-average exercise price of $    per share;    |

| • |     | shares of common stock issuable upon the exercise of outstanding stock options under 
 our 2017 Plan as of     , at a weighted-average exercise price of $    per share;    |

| • |     | shares of common stock issuable upon the exercise of outstanding stock options       
 granted subsequent to     , at a weighted-average exercise price of $     per share; |

| • |     | shares of our common stock issuable upon the exercise of Class A common stock                                                                                                       
 warrants outstanding as of     , with an exercise price of $0.01 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—Class A Warrants;” |

| • |     | shares of our common stock issuable upon the exercise of Class B common stock                                                                                                       
 warrants outstanding as of     , with an exercise price of $0.01 per share, as more fully described in the section titled “Description of Capital Stock—Warrants—Class B Warrants;” |

| • |     | shares of our common stock issuable to Maxim Partners LLC